Point72 Asset Management’s Kite Pharma KITE Stock Holding History
Bought
Maintained
Sold
Other funds holding KITE
Point72 Asset Management's KITE Position: Q3 2017 in Review
Point72 Asset Management sold out of Kite Pharma (KITE) in Q3 2017, closing a stake of 437,969 shares — an estimated $45.4M sold.
Point72 Asset Management first reported a position in KITE in Q4 2016 and held it in 3 quarters. The position peaked at $64.4M in Q1 2017. 244 funds tracked by Wall St. Rank hold KITE as of Q3 2017.
- Point72 Asset Management reported no remaining Kite Pharma position as of Q3 2017 after selling out during the quarter.
- Point72 Asset Management sold 437,969 Kite Pharma shares in Q3 2017, an estimated $45.4M.
- Point72 Asset Management first reported a position in Kite Pharma in Q4 2016 and held it in 3 quarters.
- Point72 Asset Management's Kite Pharma position peaked at $64.4M in Q1 2017.
- 244 funds tracked by Wall St. Rank held Kite Pharma as of Q3 2017.
Based on Point72 Asset Management's 13F filing for Q3 2017, filed 14 Nov 2017.